Imaging in Pancreatic Cancer: Radiologist's Insights

14th International Gastrointestinal Cancers Conference (IGICC2024)

V. Đurović Sarajlić

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

DDW 2024 Highlights: Pancreatic Cancer Screening in High Risk Indivi…

DDW 2024 Conference Coverage

T. Kachaamy

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Breast Imaging and the Young Patient

Cleveland Clinic Taussig Cancer Institute

L. Dean

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

Pancreas Cancer: Update and Review

Scripps Health

W. Coyle

ASCO® GI 2025 Insights: Serum MUC5AC as a Predictor of Outcomes and …

Insights from 2025 ASCO® GI Annual Meeting

A. Manne

Management of AL Amyloidosis

GRACE

S. Rajeeve

Pancreatic Cancer Risk in Prediabetic Individuals

Akhil Jain

Radiation Oncology: Basic Principles and Updates in 2024

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

J. Chen

Evolving Treatment Landscape in ITP

Robert Bird

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Indy Hematology Review

R. Rampal

Pulmonary irAEs: Epidemiology, Diagnosis, and Treatment of ICI-P

Cleveland Clinic Taussig Cancer Institute

M. Smith